Larimar Therapeutics (NASDAQ:LRMR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Larimar Therapeutics (LRMR) operate in?

Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Larimar Therapeutics Stock (NASDAQ: LRMR) stock price, news, charts, stock research, profile.

Open	$3.95
Close	$4.01
Volume / Avg.	1.14M / 885.41K
Day Range	$3.87 - $4.17
52 Wk Range	3.01 - 13.68
Market Cap	$260.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	9.31%
Days to Cover	5.82

Recent News

What's Going On With Larimar Therapeutics Stock On Tuesday?

Larimar Therapeutics reports promising FXN level increases with 25 mg nomlabofusp, advancing towards dose escalation for Friedreich's Ataxia treatment.

Vandana Singh

Crude Oil Down 1%; Webuy Global Shares Spike Higher

Avi Kapoor

Why Is Larimar Therapeutics Stock Trading Lower On Monday?

Larimar Therapeutics shares long-term OLE study data on nomlabofusp, showing increased FXN levels in Friedreich's Ataxia patients and well-tolerated treatment.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.95
Close	$4.01
Volume / Avg.	1.14M / 885.41K
Day Range	$3.87 - $4.17
52 Wk Range	3.01 - 13.68
Market Cap	$260.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	28
Short Interest	9.31%
Days to Cover	5.82

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Larimar Therapeutics (LRMR) stock?

You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.

View our list of the best stock brokerages

Who are Larimar Therapeutics (LRMR) competitors?

Other companies in Larimar Therapeutics’s space includes: Renovaro (NASDAQ:RENB), 4D Molecular Therapeutics (NASDAQ:FDMT), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL) and Eledon Pharma (NASDAQ:ELDN).

What is the forecast, or price target, for Larimar Therapeutics (LRMR) stock?

Larimar Therapeutics has a consensus price target of $19.00.

What is the current price for Larimar Therapeutics (LRMR)?

The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $4.09 last updated December 20, 2024 at 4:21 PM EST.

Does Larimar Therapeutics (LRMR) pay a dividend?

There are no upcoming dividends for Larimar Therapeutics.

When is Larimar Therapeutics (NASDAQ:LRMR) reporting earnings?

Larimar Therapeutics’s Q4 earnings are confirmed for Thursday, March 13, 2025.

Is Larimar Therapeutics (LRMR) going to split?

There is no upcoming split for Larimar Therapeutics.

What sector and industry does Larimar Therapeutics (LRMR) operate in?

Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Larimar Therapeutics

Larimar Therapeutics (LRMR) Forecast